Larvol Delta - Bold-Therapeutics-Presents-Positive-Interim-Phase-2-Results-for-BOLD100-in-Advanced-Gastric-and-Biliary-Tract-Cancer-at-ASCO-2023

BOLD-100 - Bold Therap, Intezyne

https://www.prnewswire.com/news-releases/bold-therapeutics-presents-positive-interim-phase-2-results-for-bold-100-in-advanced-gastric-and-biliary-tract-cancer-at-asco-2023-301843600.html

Jun 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next